NCT06492720View on ClinicalTrials.gov

A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

August 10, 2026

Conditions
Drug Resistant EpilepsyEpilepsyEpilepsy, Temporal Lobe
Interventions
DEVICE

Focused ultrasound (FUS) treatment

The mechanism of action of FUS neuromodulation involves the activation of voltage-gated ion channels to induce temporary neuromodulation.

Trial Locations (1)

Unknown

RECRUITING

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

NaviFUS Corporation

INDUSTRY